APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Gemcitabine Hydrochloride API

Compare research editions
View pricing & licenses

Selected research

Industry Research

Gemcitabine Hydrochloride API Industry Research Report 2026

Report ID 173276240526 December 2025127 pages

Choose your research edition.

Industry ResearchGemcitabine Hydrochloride API Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Gemcitabine Hydrochloride API Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Gemcitabine Hydrochloride API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gemcitabine Hydrochloride API Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Gemcitabine Hydrochloride API Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Gemcitabine Hydrochloride API market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Gemcitabine Hydrochloride API is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Gemcitabine Hydrochloride API is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Gemcitabine Hydrochloride API is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Gemcitabine Hydrochloride API include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Gemcitabine Hydrochloride API market in revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Gemcitabine Hydrochloride API.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Gemcitabine Hydrochloride API Market by Company

Zhejiang Hisun Pharmaceutical

Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical

Shanghai Chuangnuo Pharmaceutical

Shandong Anhong Pharmaceutical

Fu'an Pharmaceutical Group

Hubei Bantian Pharmaceutical

Jiangsu Hansoh Pharmaceutical Group

Jiangsu Zhengda Qingjiang Pharmaceutical

Lianyungang Jerry Pharmaceutical

Shandong Luoxin Pharmaceutical Group

Lianyungang Runzhong Pharmaceutical

Sanofi

Gemcitabine Hydrochloride API Segment by Type

0.98

0.99

Others

Gemcitabine Hydrochloride API Segment by Application

Pharmaceutical

Research

Gemcitabine Hydrochloride API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gemcitabine Hydrochloride API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gemcitabine Hydrochloride API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gemcitabine Hydrochloride API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Gemcitabine Hydrochloride API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Gemcitabine Hydrochloride API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Gemcitabine Hydrochloride API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Gemcitabine Hydrochloride API Production by Manufacturers (Tons) & (2021-2026) Table 6. Global Gemcitabine Hydrochloride API Production Market Share by Manufacturers Table 7. Global Gemcitabine Hydrochloride API Production Value by Manufacturers (US$ Million) & (2021-2026) Table 8. Global Gemcitabine Hydrochloride API Production Value Market Share by Manufacturers (2021-2026) Table 9. Global Gemcitabine Hydrochloride API Average Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Gemcitabine Hydrochloride API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Gemcitabine Hydrochloride API Key Manufacturers, Manufacturing Sites & Headquarters Table 12. Global Gemcitabine Hydrochloride API Manufacturers, Product Type & Application Table 13. Global Gemcitabine Hydrochloride API Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Gemcitabine Hydrochloride API by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans Table 17. Zhejiang Hisun Pharmaceutical Company Information Table 18. Zhejiang Hisun Pharmaceutical Business Overview Table 19. Zhejiang Hisun Pharmaceutical Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 20. Zhejiang Hisun Pharmaceutical Gemcitabine Hydrochloride API Product Portfolio Table 21. Zhejiang Hisun Pharmaceutical Recent Development Table 22. Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical Company Information Table 23. Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical Business Overview Table 24. Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 25. Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical Gemcitabine Hydrochloride API Product Portfolio Table 26. Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical Recent Development Table 27. Shanghai Chuangnuo Pharmaceutical Company Information Table 28. Shanghai Chuangnuo Pharmaceutical Business Overview Table 29. Shanghai Chuangnuo Pharmaceutical Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 30. Shanghai Chuangnuo Pharmaceutical Gemcitabine Hydrochloride API Product Portfolio Table 31. Shanghai Chuangnuo Pharmaceutical Recent Development Table 32. Shandong Anhong Pharmaceutical Company Information Table 33. Shandong Anhong Pharmaceutical Business Overview Table 34. Shandong Anhong Pharmaceutical Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 35. Shandong Anhong Pharmaceutical Gemcitabine Hydrochloride API Product Portfolio Table 36. Shandong Anhong Pharmaceutical Recent Development Table 37. Fu'an Pharmaceutical Group Company Information Table 38. Fu'an Pharmaceutical Group Business Overview Table 39. Fu'an Pharmaceutical Group Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 40. Fu'an Pharmaceutical Group Gemcitabine Hydrochloride API Product Portfolio Table 41. Fu'an Pharmaceutical Group Recent Development Table 42. Hubei Bantian Pharmaceutical Company Information Table 43. Hubei Bantian Pharmaceutical Business Overview Table 44. Hubei Bantian Pharmaceutical Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 45. Hubei Bantian Pharmaceutical Gemcitabine Hydrochloride API Product Portfolio Table 46. Hubei Bantian Pharmaceutical Recent Development Table 47. Jiangsu Hansoh Pharmaceutical Group Company Information Table 48. Jiangsu Hansoh Pharmaceutical Group Business Overview Table 49. Jiangsu Hansoh Pharmaceutical Group Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 50. Jiangsu Hansoh Pharmaceutical Group Gemcitabine Hydrochloride API Product Portfolio Table 51. Jiangsu Hansoh Pharmaceutical Group Recent Development Table 52. Jiangsu Zhengda Qingjiang Pharmaceutical Company Information Table 53. Jiangsu Zhengda Qingjiang Pharmaceutical Business Overview Table 54. Jiangsu Zhengda Qingjiang Pharmaceutical Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 55. Jiangsu Zhengda Qingjiang Pharmaceutical Gemcitabine Hydrochloride API Product Portfolio Table 56. Jiangsu Zhengda Qingjiang Pharmaceutical Recent Development Table 57. Lianyungang Jerry Pharmaceutical Company Information Table 58. Lianyungang Jerry Pharmaceutical Business Overview Table 59. Lianyungang Jerry Pharmaceutical Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 60. Lianyungang Jerry Pharmaceutical Gemcitabine Hydrochloride API Product Portfolio Table 61. Lianyungang Jerry Pharmaceutical Recent Development Table 62. Shandong Luoxin Pharmaceutical Group Company Information Table 63. Shandong Luoxin Pharmaceutical Group Business Overview Table 64. Shandong Luoxin Pharmaceutical Group Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 65. Shandong Luoxin Pharmaceutical Group Gemcitabine Hydrochloride API Product Portfolio Table 66. Shandong Luoxin Pharmaceutical Group Recent Development Table 67. Lianyungang Runzhong Pharmaceutical Company Information Table 68. Lianyungang Runzhong Pharmaceutical Business Overview Table 69. Lianyungang Runzhong Pharmaceutical Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 70. Lianyungang Runzhong Pharmaceutical Gemcitabine Hydrochloride API Product Portfolio Table 71. Lianyungang Runzhong Pharmaceutical Recent Development Table 72. Sanofi Company Information Table 73. Sanofi Business Overview Table 74. Sanofi Gemcitabine Hydrochloride API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 75. Sanofi Gemcitabine Hydrochloride API Product Portfolio Table 76. Sanofi Recent Development Table 77. Global Gemcitabine Hydrochloride API Production Comparison by Region: 2021 VS 2025 VS 2032 (Tons) Table 78. Global Gemcitabine Hydrochloride API Production by Region (2021-2026) & (Tons) Table 79. Global Gemcitabine Hydrochloride API Production Market Share by Region (2021-2026) Table 80. Global Gemcitabine Hydrochloride API Production Forecast by Region (2027-2032) & (Tons) Table 81. Global Gemcitabine Hydrochloride API Production Market Share Forecast by Region (2027-2032) Table 82. Global Gemcitabine Hydrochloride API Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 83. Global Gemcitabine Hydrochloride API Production Value by Region (2021-2026) & (US$ Million) Table 84. Global Gemcitabine Hydrochloride API Production Value Market Share by Region (2021-2026) Table 85. Global Gemcitabine Hydrochloride API Production Value Forecast by Region (2027-2032) & (US$ Million) Table 86. Global Gemcitabine Hydrochloride API Market Average Price (US$/Ton) by Region (2021-2026) Table 87. Global Gemcitabine Hydrochloride API Market Average Price (US$/Ton) by Region (2027-2032) Table 88. Global Gemcitabine Hydrochloride API Consumption Comparison by Region: 2021 VS 2025 VS 2032 (Tons) Table 89. Global Gemcitabine Hydrochloride API Consumption by Region (2021-2026) & (Tons) Table 90. Global Gemcitabine Hydrochloride API Consumption Market Share by Region (2021-2026) Table 91. Global Gemcitabine Hydrochloride API Forecasted Consumption by Region (2027-2032) & (Tons) Table 92. Global Gemcitabine Hydrochloride API Forecasted Consumption Market Share by Region (2027-2032) Table 93. North America Gemcitabine Hydrochloride API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 94. North America Gemcitabine Hydrochloride API Consumption by Country (2021-2026) & (Tons) Table 95. North America Gemcitabine Hydrochloride API Consumption by Country (2027-2032) & (Tons) Table 96. Europe Gemcitabine Hydrochloride API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 97. Europe Gemcitabine Hydrochloride API Consumption by Country (2021-2026) & (Tons) Table 98. Europe Gemcitabine Hydrochloride API Consumption by Country (2027-2032) & (Tons) Table 99. Asia Pacific Gemcitabine Hydrochloride API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 100. Asia Pacific Gemcitabine Hydrochloride API Consumption by Country (2021-2026) & (Tons) Table 101. Asia Pacific Gemcitabine Hydrochloride API Consumption by Country (2027-2032) & (Tons) Table 102. South America, Middle East & Africa Gemcitabine Hydrochloride API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 103. South America, Middle East & Africa Gemcitabine Hydrochloride API Consumption by Country (2021-2026) & (Tons) Table 104. South America, Middle East & Africa Gemcitabine Hydrochloride API Consumption by Country (2027-2032) & (Tons) Table 105. Global Gemcitabine Hydrochloride API Production by Type (2021-2026) & (Tons) Table 106. Global Gemcitabine Hydrochloride API Production by Type (2027-2032) & (Tons) Table 107. Global Gemcitabine Hydrochloride API Production Market Share by Type (2021-2026) Table 108. Global Gemcitabine Hydrochloride API Production Market Share by Type (2027-2032) Table 109. Global Gemcitabine Hydrochloride API Production Value by Type (2021-2026) & (US$ Million) Table 110. Global Gemcitabine Hydrochloride API Production Value by Type (2027-2032) & (US$ Million) Table 111. Global Gemcitabine Hydrochloride API Production Value Market Share by Type (2021-2026) Table 112. Global Gemcitabine Hydrochloride API Production Value Market Share by Type (2027-2032) Table 113. Global Gemcitabine Hydrochloride API Price by Type (2021-2026) & (US$/Ton) Table 114. Global Gemcitabine Hydrochloride API Price by Type (2027-2032) & (US$/Ton) Table 115. Global Gemcitabine Hydrochloride API Production by Application (2021-2026) & (Tons) Table 116. Global Gemcitabine Hydrochloride API Production by Application (2027-2032) & (Tons) Table 117. Global Gemcitabine Hydrochloride API Production Market Share by Application (2021-2026) Table 118. Global Gemcitabine Hydrochloride API Production Market Share by Application (2027-2032) Table 119. Global Gemcitabine Hydrochloride API Production Value by Application (2021-2026) & (US$ Million) Table 120. Global Gemcitabine Hydrochloride API Production Value by Application (2027-2032) & (US$ Million) Table 121. Global Gemcitabine Hydrochloride API Production Value Market Share by Application (2021-2026) Table 122. Global Gemcitabine Hydrochloride API Production Value Market Share by Application (2027-2032) Table 123. Global Gemcitabine Hydrochloride API Price by Application (2021-2026) & (US$/Ton) Table 124. Global Gemcitabine Hydrochloride API Price by Application (2027-2032) & (US$/Ton) Table 125. Key Raw Materials Table 126. Raw Materials Key Suppliers Table 127. Gemcitabine Hydrochloride API Distributors List Table 128. Gemcitabine Hydrochloride API Customers List Table 129. Gemcitabine Hydrochloride API Industry Trends Table 130. Gemcitabine Hydrochloride API Industry Drivers Table 131. Gemcitabine Hydrochloride API Industry Restraints Table 132. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Gemcitabine Hydrochloride API Product Image Figure 5. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. 0.98 Product Image Figure 7. 0.99 Product Image Figure 8. Others Product Image Figure 9. Pharmaceutical Product Image Figure 10. Research Product Image Figure 11. Global Gemcitabine Hydrochloride API Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Gemcitabine Hydrochloride API Production Value (2021-2032) & (US$ Million) Figure 13. Global Gemcitabine Hydrochloride API Production Capacity (2021-2032) & (Tons) Figure 14. Global Gemcitabine Hydrochloride API Production (2021-2032) & (Tons) Figure 15. Global Gemcitabine Hydrochloride API Average Price (US$/Ton) & (2021-2032) Figure 16. Global Gemcitabine Hydrochloride API Key Manufacturers, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Gemcitabine Hydrochloride API Players Market Share by Production Value in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Gemcitabine Hydrochloride API Production Comparison by Region: 2021 VS 2025 VS 2032 (Tons) Figure 20. Global Gemcitabine Hydrochloride API Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 21. Global Gemcitabine Hydrochloride API Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Gemcitabine Hydrochloride API Production Value Market Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Gemcitabine Hydrochloride API Production Value (US$ Million) Growth Rate (2021-2032) Figure 24. Europe Gemcitabine Hydrochloride API Production Value (US$ Million) Growth Rate (2021-2032) Figure 25. China Gemcitabine Hydrochloride API Production Value (US$ Million) Growth Rate (2021-2032) Figure 26. Japan Gemcitabine Hydrochloride API Production Value (US$ Million) Growth Rate (2021-2032) Figure 27. Global Gemcitabine Hydrochloride API Consumption Comparison by Region: 2021 VS 2025 VS 2032 (Tons) Figure 28. Global Gemcitabine Hydrochloride API Consumption Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 30. North America Gemcitabine Hydrochloride API Consumption Market Share by Country (2021-2032) Figure 31. United States Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 32. United States Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 33. Canada Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 34. Mexico Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 35. Europe Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 36. Europe Gemcitabine Hydrochloride API Consumption Market Share by Country (2021-2032) Figure 37. Germany Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 38. France Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 39. U.K. Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 40. Italy Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 41. Russia Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 42. Spain Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 43. Netherlands Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 44. Switzerland Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 45. Sweden Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 46. Poland Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 47. Asia Pacific Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 48. Asia Pacific Gemcitabine Hydrochloride API Consumption Market Share by Country (2021-2032) Figure 49. China Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 50. Japan Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 51. South Korea Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 52. India Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 53. Australia Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 54. Taiwan Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 55. Southeast Asia Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 56. South America, Middle East & Africa Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 57. South America, Middle East & Africa Gemcitabine Hydrochloride API Consumption Market Share by Country (2021-2032) Figure 58. Brazil Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 59. Argentina Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 60. Chile Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 61. Turkey Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 62. GCC Countries Gemcitabine Hydrochloride API Consumption and Growth Rate (2021-2032) & (Tons) Figure 63. Global Gemcitabine Hydrochloride API Production Market Share by Type (2021-2032) Figure 64. Global Gemcitabine Hydrochloride API Production Value Market Share by Type (2021-2032) Figure 65. Global Gemcitabine Hydrochloride API Price (US$/Ton) by Type (2021-2032) Figure 66. Global Gemcitabine Hydrochloride API Production Market Share by Application (2021-2032) Figure 67. Global Gemcitabine Hydrochloride API Production Value Market Share by Application (2021-2032) Figure 68. Global Gemcitabine Hydrochloride API Price (US$/Ton) by Application (2021-2032) Figure 69. Gemcitabine Hydrochloride API Value Chain Figure 70. Gemcitabine Hydrochloride API Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Gemcitabine Hydrochloride API Industry Opportunities and Challenges

Scope & coverage.

Types
  • 0.98
  • 0.99
  • Others
Applications
  • Pharmaceutical
  • Research
Companies covered
  • Zhejiang Hisun Pharmaceutical
  • Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical
  • Shanghai Chuangnuo Pharmaceutical
  • Shandong Anhong Pharmaceutical
  • Fu'an Pharmaceutical Group
  • Hubei Bantian Pharmaceutical
  • Jiangsu Hansoh Pharmaceutical Group
  • Jiangsu Zhengda Qingjiang Pharmaceutical
  • Lianyungang Jerry Pharmaceutical
  • Shandong Luoxin Pharmaceutical Group
  • Lianyungang Runzhong Pharmaceutical
  • Sanofi

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Gemcitabine Hydrochloride API by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  4. 2.2.2 0.98
  5. 2.2.3 0.99
  6. 2.2.4 Others
  7. 2.3 Gemcitabine Hydrochloride API by Application
  8. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
  9. 2.3.2 Pharmaceutical
  10. 2.3.3 Research
  11. 2.4 Global Market Growth Prospects
  12. 2.4.1 Global Gemcitabine Hydrochloride API Production Value Estimates and Forecasts (2021-2032)
  13. 2.4.2 Global Gemcitabine Hydrochloride API Production Capacity Estimates and Forecasts (2021-2032)
  14. 2.4.3 Global Gemcitabine Hydrochloride API Production Estimates and Forecasts (2021-2032)
  15. 2.4.4 Global Gemcitabine Hydrochloride API Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Gemcitabine Hydrochloride API Production by Manufacturers (2021-2026)
  2. 3.2 Global Gemcitabine Hydrochloride API Production Value by Manufacturers (2021-2026)
  3. 3.3 Global Gemcitabine Hydrochloride API Average Price by Manufacturers (2021-2026)
  4. 3.4 Global Gemcitabine Hydrochloride API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Gemcitabine Hydrochloride API Key Manufacturers, Manufacturing Sites & Headquarters
  6. 3.6 Global Gemcitabine Hydrochloride API Manufacturers, Product Type & Application
  7. 3.7 Global Gemcitabine Hydrochloride API Manufacturers Established Date
  8. 3.8 Global Gemcitabine Hydrochloride API Market CR5 and HHI
  9. 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Zhejiang Hisun Pharmaceutical
  2. 4.1.1 Zhejiang Hisun Pharmaceutical Gemcitabine Hydrochloride API Company Information
  3. 4.1.2 Zhejiang Hisun Pharmaceutical Gemcitabine Hydrochloride API Business Overview
  4. 4.1.3 Zhejiang Hisun Pharmaceutical Gemcitabine Hydrochloride API Production Capacity, Value and Gross Margin (2021-2026)
  5. 4.1.4 Zhejiang Hisun Pharmaceutical Product Portfolio
  6. 4.1.5 Zhejiang Hisun Pharmaceutical Recent Developments
  7. 4.2 Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical
  8. 4.2.1 Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical Gemcitabine Hydrochloride API Company Information
  9. 4.2.2 Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical Gemcitabine Hydrochloride API Business Overview
  10. 4.2.3 Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical Gemcitabine Hydrochloride API Production Capacity, Value and Gross Margin (2021-2026)
  11. 4.2.4 Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical Product Portfolio
  12. 4.2.5 Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical Recent Developments
  13. 4.3 Shanghai Chuangnuo Pharmaceutical
  14. 4.3.1 Shanghai Chuangnuo Pharmaceutical Gemcitabine Hydrochloride API Company Information
  15. 4.3.2 Shanghai Chuangnuo Pharmaceutical Gemcitabine Hydrochloride API Business Overview
  16. 4.3.3 Shanghai Chuangnuo Pharmaceutical Gemcitabine Hydrochloride API Production Capacity, Value and Gross Margin (2021-2026)
  17. 4.3.4 Shanghai Chuangnuo Pharmaceutical Product Portfolio
  18. 4.3.5 Shanghai Chuangnuo Pharmaceutical Recent Developments
  19. 4.4 Shandong Anhong Pharmaceutical
  20. 4.4.1 Shandong Anhong Pharmaceutical Gemcitabine Hydrochloride API Company Information
  21. 4.4.2 Shandong Anhong Pharmaceutical Gemcitabine Hydrochloride API Business Overview
  22. 4.4.3 Shandong Anhong Pharmaceutical Gemcitabine Hydrochloride API Production Capacity, Value and Gross Margin (2021-2026)
  23. 4.4.4 Shandong Anhong Pharmaceutical Product Portfolio
  24. 4.4.5 Shandong Anhong Pharmaceutical Recent Developments
  25. 4.5 Fu'an Pharmaceutical Group
  26. 4.5.1 Fu'an Pharmaceutical Group Gemcitabine Hydrochloride API Company Information
  27. 4.5.2 Fu'an Pharmaceutical Group Gemcitabine Hydrochloride API Business Overview
  28. 4.5.3 Fu'an Pharmaceutical Group Gemcitabine Hydrochloride API Production Capacity, Value and Gross Margin (2021-2026)
  29. 4.5.4 Fu'an Pharmaceutical Group Product Portfolio
  30. 4.5.5 Fu'an Pharmaceutical Group Recent Developments
  31. 4.6 Hubei Bantian Pharmaceutical
  32. 4.6.1 Hubei Bantian Pharmaceutical Gemcitabine Hydrochloride API Company Information
  33. 4.6.2 Hubei Bantian Pharmaceutical Gemcitabine Hydrochloride API Business Overview
  34. 4.6.3 Hubei Bantian Pharmaceutical Gemcitabine Hydrochloride API Production Capacity, Value and Gross Margin (2021-2026)
  35. 4.6.4 Hubei Bantian Pharmaceutical Product Portfolio
  36. 4.6.5 Hubei Bantian Pharmaceutical Recent Developments
  37. 4.7 Jiangsu Hansoh Pharmaceutical Group
  38. 4.7.1 Jiangsu Hansoh Pharmaceutical Group Gemcitabine Hydrochloride API Company Information
  39. 4.7.2 Jiangsu Hansoh Pharmaceutical Group Gemcitabine Hydrochloride API Business Overview
  40. 4.7.3 Jiangsu Hansoh Pharmaceutical Group Gemcitabine Hydrochloride API Production Capacity, Value and Gross Margin (2021-2026)
  41. 4.7.4 Jiangsu Hansoh Pharmaceutical Group Product Portfolio
  42. 4.7.5 Jiangsu Hansoh Pharmaceutical Group Recent Developments
  43. 4.8 Jiangsu Zhengda Qingjiang Pharmaceutical
  44. 4.8.1 Jiangsu Zhengda Qingjiang Pharmaceutical Gemcitabine Hydrochloride API Company Information
  45. 4.8.2 Jiangsu Zhengda Qingjiang Pharmaceutical Gemcitabine Hydrochloride API Business Overview
  46. 4.8.3 Jiangsu Zhengda Qingjiang Pharmaceutical Gemcitabine Hydrochloride API Production Capacity, Value and Gross Margin (2021-2026)
  47. 4.8.4 Jiangsu Zhengda Qingjiang Pharmaceutical Product Portfolio
  48. 4.8.5 Jiangsu Zhengda Qingjiang Pharmaceutical Recent Developments
  49. 4.9 Lianyungang Jerry Pharmaceutical
  50. 4.9.1 Lianyungang Jerry Pharmaceutical Gemcitabine Hydrochloride API Company Information
  51. 4.9.2 Lianyungang Jerry Pharmaceutical Gemcitabine Hydrochloride API Business Overview
  52. 4.9.3 Lianyungang Jerry Pharmaceutical Gemcitabine Hydrochloride API Production Capacity, Value and Gross Margin (2021-2026)
  53. 4.9.4 Lianyungang Jerry Pharmaceutical Product Portfolio
  54. 4.9.5 Lianyungang Jerry Pharmaceutical Recent Developments
  55. 4.10 Shandong Luoxin Pharmaceutical Group
  56. 4.10.1 Shandong Luoxin Pharmaceutical Group Gemcitabine Hydrochloride API Company Information
  57. 4.10.2 Shandong Luoxin Pharmaceutical Group Gemcitabine Hydrochloride API Business Overview
  58. 4.10.3 Shandong Luoxin Pharmaceutical Group Gemcitabine Hydrochloride API Production Capacity, Value and Gross Margin (2021-2026)
  59. 4.10.4 Shandong Luoxin Pharmaceutical Group Product Portfolio
  60. 4.10.5 Shandong Luoxin Pharmaceutical Group Recent Developments
  61. 4.11 Lianyungang Runzhong Pharmaceutical
  62. 4.11.1 Lianyungang Runzhong Pharmaceutical Gemcitabine Hydrochloride API Company Information
  63. 4.11.2 Lianyungang Runzhong Pharmaceutical Gemcitabine Hydrochloride API Business Overview
  64. 4.11.3 Lianyungang Runzhong Pharmaceutical Gemcitabine Hydrochloride API Production Capacity, Value and Gross Margin (2021-2026)
  65. 4.11.4 Lianyungang Runzhong Pharmaceutical Product Portfolio
  66. 4.11.5 Lianyungang Runzhong Pharmaceutical Recent Developments
  67. 4.12 Sanofi
  68. 4.12.1 Sanofi Gemcitabine Hydrochloride API Company Information
  69. 4.12.2 Sanofi Gemcitabine Hydrochloride API Business Overview
  70. 4.12.3 Sanofi Gemcitabine Hydrochloride API Production Capacity, Value and Gross Margin (2021-2026)
  71. 4.12.4 Sanofi Product Portfolio
  72. 4.12.5 Sanofi Recent Developments
5 Global Gemcitabine Hydrochloride API Production by Region
  1. 5.1 Global Gemcitabine Hydrochloride API Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Gemcitabine Hydrochloride API Production by Region: 2021-2032
  3. 5.2.1 Global Gemcitabine Hydrochloride API Production by Region: 2021-2026
  4. 5.2.2 Global Gemcitabine Hydrochloride API Production Forecast by Region (2027-2032)
  5. 5.3 Global Gemcitabine Hydrochloride API Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  6. 5.4 Global Gemcitabine Hydrochloride API Production Value by Region: 2021-2032
  7. 5.4.1 Global Gemcitabine Hydrochloride API Production Value by Region: 2021-2026
  8. 5.4.2 Global Gemcitabine Hydrochloride API Production Value Forecast by Region (2027-2032)
  9. 5.5 Global Gemcitabine Hydrochloride API Market Price Analysis by Region (2021-2026)
  10. 5.6 Global Gemcitabine Hydrochloride API Production and Value, YOY Growth
  11. 5.6.1 North America Gemcitabine Hydrochloride API Production Value Estimates and Forecasts (2021-2032)
  12. 5.6.2 Europe Gemcitabine Hydrochloride API Production Value Estimates and Forecasts (2021-2032)
  13. 5.6.3 China Gemcitabine Hydrochloride API Production Value Estimates and Forecasts (2021-2032)
  14. 5.6.4 Japan Gemcitabine Hydrochloride API Production Value Estimates and Forecasts (2021-2032)
6 Global Gemcitabine Hydrochloride API Consumption by Region
  1. 6.1 Global Gemcitabine Hydrochloride API Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gemcitabine Hydrochloride API Consumption by Region (2021-2032)
  3. 6.2.1 Global Gemcitabine Hydrochloride API Consumption by Region: 2021-2026
  4. 6.2.2 Global Gemcitabine Hydrochloride API Forecasted Consumption by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Gemcitabine Hydrochloride API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Gemcitabine Hydrochloride API Consumption by Country (2021-2032)
  8. 6.3.3 United States
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Gemcitabine Hydrochloride API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Gemcitabine Hydrochloride API Consumption by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Russia
  19. 6.4.8 Spain
  20. 6.4.9 Netherlands
  21. 6.4.10 Switzerland
  22. 6.4.11 Sweden
  23. 6.4.12 Poland
  24. 6.5 Asia Pacific
  25. 6.5.1 Asia Pacific Gemcitabine Hydrochloride API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  26. 6.5.2 Asia Pacific Gemcitabine Hydrochloride API Consumption by Country (2021-2032)
  27. 6.5.3 China
  28. 6.5.4 Japan
  29. 6.5.5 South Korea
  30. 6.5.6 India
  31. 6.5.7 Australia
  32. 6.5.8 Taiwan
  33. 6.5.9 Southeast Asia
  34. 6.6 South America, Middle East & Africa
  35. 6.6.1 South America, Middle East & Africa Gemcitabine Hydrochloride API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  36. 6.6.2 South America, Middle East & Africa Gemcitabine Hydrochloride API Consumption by Country (2021-2032)
  37. 6.6.3 Brazil
  38. 6.6.4 Argentina
  39. 6.6.5 Chile
  40. 6.6.6 Turkey
  41. 6.6.7 GCC Countries
7 Segment by Type
  1. 7.1 Global Gemcitabine Hydrochloride API Production by Type (2021-2032)
  2. 7.1.1 Global Gemcitabine Hydrochloride API Production by Type (2021-2032) & (Tons)
  3. 7.1.2 Global Gemcitabine Hydrochloride API Production Market Share by Type (2021-2032)
  4. 7.2 Global Gemcitabine Hydrochloride API Production Value by Type (2021-2032)
  5. 7.2.1 Global Gemcitabine Hydrochloride API Production Value by Type (2021-2032) & (US$ Million)
  6. 7.2.2 Global Gemcitabine Hydrochloride API Production Value Market Share by Type (2021-2032)
  7. 7.3 Global Gemcitabine Hydrochloride API Price by Type (2021-2032)
8 Segment by Application
  1. 8.1 Global Gemcitabine Hydrochloride API Production by Application (2021-2032)
  2. 8.1.1 Global Gemcitabine Hydrochloride API Production by Application (2021-2032) & (Tons)
  3. 8.1.2 Global Gemcitabine Hydrochloride API Production Market Share by Application (2021-2032)
  4. 8.2 Global Gemcitabine Hydrochloride API Production Value by Application (2021-2032)
  5. 8.2.1 Global Gemcitabine Hydrochloride API Production Value by Application (2021-2032) & (US$ Million)
  6. 8.2.2 Global Gemcitabine Hydrochloride API Production Value Market Share by Application (2021-2032)
  7. 8.3 Global Gemcitabine Hydrochloride API Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
  1. 9.1 Gemcitabine Hydrochloride API Value Chain Analysis
  2. 9.1.1 Gemcitabine Hydrochloride API Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Gemcitabine Hydrochloride API Production Mode & Process
  5. 9.2 Gemcitabine Hydrochloride API Sales Channels Analysis
  6. 9.2.1 Direct Comparison with Distribution Share
  7. 9.2.2 Gemcitabine Hydrochloride API Distributors
  8. 9.2.3 Gemcitabine Hydrochloride API Customers
10 Global Gemcitabine Hydrochloride API Analyzing Market Dynamics
  1. 10.1 Gemcitabine Hydrochloride API Industry Trends
  2. 10.2 Gemcitabine Hydrochloride API Industry Drivers
  3. 10.3 Gemcitabine Hydrochloride API Industry Opportunities and Challenges
  4. 10.4 Gemcitabine Hydrochloride API Industry Restraints
11 Report Conclusion
    12 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst